Sign In
Buy OVID
$2.44
-0.0100 (-0.408%)
At Close: Jul 17, 2026
Comunicado do Business Wire :Takeda Pharmaceutical Company Limited & Neurocrine Biosciences, Inc.
04:01pm, Tuesday, 16'th Jun 2020
A Neurocrine Biosciences, Inc
Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Commercialize Potential Therapies for Psychiatric Disorders
11:01am, Tuesday, 16'th Jun 2020
Strategic partnership agreement provides Neurocrine Biosciences exclusive worldwide rights to early-to-mid-stage psychiatry pipeline compounds within Takeda’s Neuroscience portfolio Collaboration i�
武田呈報評估口服NINLARO™ (ixazomib)用於多發性骨髓瘤一線維持治療的臨床試驗陽性資料
12:00am, Tuesday, 16'th Jun 2020
(美國商業資訊)--武田藥品工業株式會社 (Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)（「武田」）今天宣布，將在歐洲血液學會(EHA)第25屆大會上口述呈�
− These Data Demonstrate Breadth of Takeda’s Portfolio and Pipeline with Three Hematology Presentations at the Virtual SummitOSAKA, Japan — Takeda Pharmaceutical Company Limited, (&ldqu…
-$0.38 Earnings Per Share Expected for Ovid Therapeutics Inc (NASDAQ:OVID) This Quarter
07:56am, Monday, 15'th Jun 2020
Brokerages expect Ovid Therapeutics Inc (NASDAQ:OVID) to post ($0.38) earnings per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for
US Bancorp DE Has $487,000 Holdings in Takeda Pharmaceutical Co Ltd (NYSE:TAK)
07:48am, Sunday, 14'th Jun 2020
US Bancorp DE reduced its stake in shares of Takeda Pharmaceutical Co Ltd (NYSE:TAK) by 30.0% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchang
Takeda Pharmaceutical (NYSE:TAK) Downgraded by Zacks Investment Research
06:52am, Sunday, 14'th Jun 2020
Zacks Investment Research lowered shares of Takeda Pharmaceutical (NYSE:TAK) from a hold rating to a sell rating in a research note published on Wednesday morning, Zacks.com reports. According to Zack
Takeda Pharmaceutical Company Limited (TSE : 4502/NYSE : TAK) (« Takeda ») a annoncé aujourd’hui qu’elle présenterait oralement les résultats de deux
EN DIRECT DES MARCHES : Teleperformance, Sodexo, 5G, Technicolor, Lumibird, Nestlé, Boeing, Sony, Hertz...
06:01am, Friday, 12'th Jun 2020
Takeda Pharmaceutical Company Limited (TOKYO : 4502/NYSE : TAK) (« Takeda ») a annoncé aujourd'hui l'ajout de deux partenaires à son Programme de resp
New York, June 11, Jun 11, 2020 (GLOBE NEWSWIRE via COMTEX) --
New York, June 11, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the...
